BackImmix Biopharma Overview

Immix Biopharma Other Assets

Track Immix Biopharma's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average / median

Loading

Immix Biopharma Other Assets History

Loading

Immix Biopharma vs. peers: Other Assets Comparison

Loading

Immix Biopharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immix Biopharma (IMMX) FAQ

The latest other assets for IMMX is $0 as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Immix Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMMX's other assets moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Immix Biopharma's operating scale or balance-sheet position.

A other assets figure of $0 for IMMX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMMX's other assets ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.